Day: October 3, 2024

IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain

Written by Customer Service on . Posted in Public Companies.

A EUR 16 million Initiative to Establish Strategic EU Autonomy in Alpha Therapies for Cancer Louvain-la-Neuve, Belgium, October 3, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, is pleased to announce that the European Commission has approved the financing of the Accelerate.EU project launching on October 1, 2024. IBA’s key role in this new project further reiterates its market leading role in supporting the production of novel targeted alpha therapies for cancer. As the industry leader of the Accelerate.EU initiative, IBA will facilitate the development of a production network to enable greater access to targeted alpha therapy across the EU through the development of a new alpha-machine cyclotron as an...

Continue reading

Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET

Written by Customer Service on . Posted in Public Companies.

Saint Herblain (France), October 3, 2024 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will host an investor day at the Lotte New York Palace Hotel in New York, NY on Thursday, October 10, 2024 at 10:00 AM ET (4:00 pm CET). The meeting will be conducted in a hybrid way – in person and webcast. To register, click here. The event will focus on Valneva’s robust R&D pipeline of potentially first-, only-, or best-in-class vaccine candidates addressing major unmet medical needs in infectious disease: Lyme disease (Phase 3, led by Pfizer), Shigella (Phase 2), and Zika (Phase 1). It will also highlight Valneva’s growing portfolio of revenue-generating vaccines, including the launch of the world’s first and only approved vaccine against chikungunya virus. Speakers from Company management...

Continue reading

KMT-Hansa Announces Private Placement

Written by Customer Service on . Posted in Public Companies.

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — KMT-Hansa Corp. (the “Corporation”) is pleased to announce that it has negotiated various debt conversion agreements (collectively, the “Debt Agreements”) with 7 creditors (collectively, the “Creditors”), all of which are arm’s length parties to the Corporation. Pursuant to the terms of the Debt Agreements, the Corporation has agreed to issue an aggregate of up to 28,571,428 common shares (“Debt Shares”) to the Creditors in exchange for the cancellation of up to $1 million in debt owing to the parties. The Debt Shares are being issued at a deemed price of $0.035 per Debt Share. The Debt Shares issued pursuant to the Debt Agreements are subject to a statutory four (4) month hold period. For further information please contact: Jay VieiraDirector and Chief Executive Officer Email: kmthansa@gmail.com Neither...

Continue reading

The Pennant Group Announces Pricing of Public Offering of Common Stock

Written by Customer Service on . Posted in Public Companies.

EAGLE, Idaho, Oct. 02, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG) (the “Company”) today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at a public offering price of $31.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $108.5 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock. The Company expects to use the net proceeds from the offering to repay outstanding indebtedness under the Company’s revolving credit facility and any remaining for general corporate purposes. The offering is expected to close on or about October 4, 2024, subject to customary closing conditions. Citigroup...

Continue reading

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

Written by Customer Service on . Posted in Mergers And Acquisitions.

– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM) (“Reneo”) today announced the results of the special meeting of its stockholders held on September 26, 2024. At the special meeting, Reneo’s stockholders voted in favor of all proposals, including the proposals required to complete the proposed merger of Reneo and OnKure, Inc. (“OnKure”). The closing of the merger is anticipated to take place on or around Friday, October 4, 2024. Following the closing of the merger, the combined company plans to change its name from “Reneo Pharmaceuticals, Inc.” to “OnKure Therapeutics, Inc.” and trade on The Nasdaq Global Market under the ticker symbol “OKUR.” The combined company will be led...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.